SOL Capital Management Portfolio holdings
Top Buys
Top Sells
| 1 |
Tapestry
TPR
|
+$12.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.42M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.31M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.15M |
| 5 |
iShares Short Maturity Bond ETF
NEAR
|
+$955K |
Sector Composition
| 1 | Financials | 14.45% |
| 2 | Technology | 7.36% |
| 3 | Healthcare | 5.53% |
| 4 | Consumer Discretionary | 5.17% |
| 5 | Industrials | 3.88% |
Similar funds
SOL Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, SOL Capital Management held 255 positions worth $354M, down 2.6% from $364M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
SOL Capital Management withdrew a net $24.4M in Q3 2017, closing 9 positions and reducing 112 holdings. Its most notable exit was Vanguard Short-Term Corporate Bond ETF, an estimated $1.31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, SOL Capital Management opened a new position in DuPont de Nemours worth $437K.
- SOL Capital Management's largest Q3 2017 buy was DuPont de Nemours: 2,492 shares worth $437K.
- SOL Capital Management added most to Teva Pharmaceuticals in Q3 2017, an estimated $1.27M increase.
- SOL Capital Management's biggest Q3 2017 reduction was Tapestry, cutting an estimated $12.5M.
- SOL Capital Management fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2017, selling an estimated $1.31M.
- SOL Capital Management's ten largest holdings make up 26% of its $354M portfolio in Q3 2017.
- SOL Capital Management opened 9 new positions and closed 9 in Q3 2017.
- SOL Capital Management's portfolio value fell 2.6% quarter-over-quarter to $354M.
Based on SOL Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.